Department of Pediatric Otolaryngology-Head and Neck Surgery, McGill University, Montreal Children's Hospital, Montreal, Quebec, Canada.
Otolaryngol Head Neck Surg. 2011 Dec;145(6):1022-4. doi: 10.1177/0194599811418407. Epub 2011 Aug 22.
In this prospective controlled animal study, the authors investigated the potential ototoxic effects of ototopical application of nystatin through a tympanostomy tube, using their established chinchilla animal model. Each of the 10 animals used had ventilation tubes inserted in both ears; 1 ear was randomly assigned to receive nystatin suspension, whereas the other ear did not receive any medication, serving as control. Distortion product otoacoustic emissions (DPOAEs) were measured in each animal before application of nystatin and at 45 and 60 days after application. Each cochlea was also processed for scanning electron microscopy (SEM) at the end of the experiment. There was no significant difference in the DPOAEs and SEM appearances of the experimental and control ears over the 60-day period of the experiment. The authors conclude that transtympanic nystatin did not produce any long-term ototoxic effects detectable by DPOAEs or SEM.
在这项前瞻性对照动物研究中,作者通过建立的南美栗鼠动物模型,研究了经鼓膜切开术置管局部应用制霉菌素的潜在耳毒性。使用的 10 只动物每只耳朵均插入通气管;其中一只耳朵随机接受制霉菌素混悬液,而另一只耳朵未接受任何药物,作为对照。在应用制霉菌素之前和应用后 45 和 60 天,对每个动物的畸变产物耳声发射(DPOAE)进行测量。实验结束时,每个耳蜗也进行扫描电子显微镜(SEM)处理。在实验的 60 天期间,DPOAE 和 SEM 对实验耳和对照耳的影响没有显著差异。作者得出结论,经鼓膜切开术给予制霉菌素不会产生任何可通过 DPOAE 或 SEM 检测到的长期耳毒性作用。